LIXTE BIOTECHNOLOGY HOLDINGS (LIXT)

US5393192027 - Common Stock

0.6625  -0.03 (-4.37%)

After market: 0.7 +0.04 (+5.66%)

TTM
(2023-3-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Non Recurring Items
N/AN/AN/AN/AN/A
Operating Expenses
6.03M6.31M6.72M3.27M2.49M
Interest Expense
3.99K-1.06K-7.95K0.0050.00K
Income Before Taxes
-6.02M-6.31M-6.73M-3.26M-2.44M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-6.02M-6.31M-6.73M-3.26M-2.44M
 
Per Share Data
EPS Diluted Total Ops
-0.36-0.40-0.50-0.29-0.22
 
Statistics
Profit Margin
N/AN/AN/AN/AN/A

All data in USD

Charts